Nome Químico: 2-((8S,9R,10S,13S,14S,16S,17R)-9-Fluoro-17-hydroxy-10,13,16-trimethyl-3-oxo-6,7,8,9,10,13,14,15,16,17-decahydro-3H-cyclopenta[a]phenanthren-17-yl)-2-oxoethyl propionate
Sorrisos: CCC(OCC([C@@]1(O)[C@@H](C)C[C@@]2([H])[C@]3([H])CCC4=CC(C=C[C@]4(C)[C@@]3(F)C=C[C@]12C)=O)=O)=O
Inchi: InChI=1S/C25H30O5/c1-5-21(28)29-13-19(27)22-14(2)10-18-17-7-6-15-11-16(26)8-9-24(15,4)25(17)20(30-25)12-23(18,22)3/h8-9,11,17-18,20H,5-7,10,12-13H2,1-4H3/t17-,18-,20-,23-,24-,25+/m0/s1
Application of LC–MSn in conjunction with mechanism-based stress studies in the elucidation of drug impurity structure: Rapid identification of a process impurity in betamethasone 17-valerate drug substance
Min Li, Mingxiang Lin, Abu Rustum
Journal of Pharmaceutical and Biomedical Analysis 48 (2008) 1451–1456
Development and Validation of Stability-indicating HPLC Method for Betamethoasone Dipropionate and Related Substances in Topical Formulation
A. s. vairale*, p. sivaswaroop1 and s. bandana
Indian Journal of Pharmaceutical Sciences 74(2):107-15